Genmab — April 2020
-
No one-time revenue this time?
-
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2020
Company Announcement Net sales of DARZALEX® in the first quarter of 2020 totaled USD 937 millionGenmab will receive royalties on worldwide sales from...
GlobeNewswire News Room (www.globenewswire.com)
-
Thanks E L. That's quite important
-
STÆRKT!!:-)
-
Det er faktisk overraskende flot. Når Jan direkte har været ude at forberede marekdet på en mulig nedjustering af salgs forventninger
-
Det kan være at han er begyndt at gøre tingene omvendt
-
kig igen på de US tal...
-
JV - ja US tal er til den lave ende, men hvorfor ikke fremhæve de fantatiske RoW tal. Look at the bright side ...
-
High rate of profound clonal and renal responses with Daratumumab treatment in heavily pre‐treated patients with AL amyloidosis and high bone marrow plasma cell infiltrate https://onlinelibrary.wiley.com/doi/abs/10.1002/ajh.25828
-
-
...fordi det velovervejede argument ikke længere eksisterer
-
Bemærk hvor meget JnJ generelt nedjustere med....BP bliver modsat stort set alle andre tidligere kriser også ramt retr hårdt af det her. Nogen der har hørt interviews der belyser lidt mere hvor det er de regner med at miste omsætning og/eller udgifter der stige
r?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind